NO20054144L - Use of bradykinin-B2 receptor antagonists for the treatment of osteoarthrosis - Google Patents
Use of bradykinin-B2 receptor antagonists for the treatment of osteoarthrosisInfo
- Publication number
- NO20054144L NO20054144L NO20054144A NO20054144A NO20054144L NO 20054144 L NO20054144 L NO 20054144L NO 20054144 A NO20054144 A NO 20054144A NO 20054144 A NO20054144 A NO 20054144A NO 20054144 L NO20054144 L NO 20054144L
- Authority
- NO
- Norway
- Prior art keywords
- bradykinin
- diseases
- osteoarthrosis
- treatment
- joint
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Peptider med bradykinin antagonistiske virking egner seg for fremstilling av legemidler for profilakse og av sykdommer hvis utvikling er forbundet med en forøket aktivitet av matriks-metalkpi.ril hører sykdommer som degenerative leddsykdommer, eksempelvis (N-oon;-trose, spondy.ose saii.L briisksvinn etter leddtraumer eller lengre inaktivitet av ledd etter menisk- eller patellaskader eller håndbrudd.Peptides with bradykinin antagonistic action are suitable for the preparation of drugs for prophylaxis and of diseases whose development is associated with an increased activity of matrix metal chloride, diseases such as degenerative joint diseases, for example (N-oon; L briquette after joint trauma or prolonged inactivity of joint after meniscus or patella injury or hand fracture.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10304994A DE10304994A1 (en) | 2003-02-07 | 2003-02-07 | The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis |
PCT/EP2004/000550 WO2004069266A2 (en) | 2003-02-07 | 2004-01-23 | Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054144L true NO20054144L (en) | 2005-09-06 |
NO333903B1 NO333903B1 (en) | 2013-10-14 |
Family
ID=32797325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054144A NO333903B1 (en) | 2003-02-07 | 2005-09-06 | Use of bradykinin-B2 receptor antagonists for the production of pharmaceutical agents for use in the treatment of osteoarthritis |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1594520B1 (en) |
JP (1) | JP2006516980A (en) |
KR (1) | KR20050105447A (en) |
CN (1) | CN1317029C (en) |
AR (1) | AR043036A1 (en) |
AT (1) | ATE335500T1 (en) |
AU (1) | AU2004210396A1 (en) |
BR (1) | BRPI0407333A (en) |
CA (1) | CA2514152C (en) |
CO (1) | CO5690613A2 (en) |
CY (1) | CY1105708T1 (en) |
DE (2) | DE10304994A1 (en) |
DK (1) | DK1594520T3 (en) |
ES (1) | ES2268622T3 (en) |
HK (1) | HK1085926A1 (en) |
HR (1) | HRP20050701B1 (en) |
IL (1) | IL169899A0 (en) |
MA (1) | MA27618A1 (en) |
ME (1) | MEP41008A (en) |
MX (1) | MXPA05007310A (en) |
MY (1) | MY135827A (en) |
NO (1) | NO333903B1 (en) |
NZ (1) | NZ541680A (en) |
PE (1) | PE20040939A1 (en) |
PL (1) | PL206412B1 (en) |
PT (1) | PT1594520E (en) |
RS (1) | RS51029B (en) |
RU (1) | RU2329057C2 (en) |
TW (1) | TW200505472A (en) |
WO (1) | WO2004069266A2 (en) |
ZA (1) | ZA200505177B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0710522D0 (en) * | 2007-06-01 | 2007-07-11 | Royal Veterinary College The | Drug delivery system comprising matrix metalloproteinase inhibitors |
IT1391236B1 (en) * | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | PHARMACEUTICAL COMPOSITIONS BASED ON ANTAGONISTS OF THE B2 KININE AND CORTICOSTEROID RECEPTOR AND THEIR USE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
MX9100717A (en) * | 1990-08-24 | 1992-04-01 | Syntex Inc | BRADIQUININE ANTAGONISTS |
FR2751650B1 (en) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | NOVEL N-BENZENESULFONYL-L-PROLINE COMPOUNDS, METHOD OF PREPARATION AND THERAPEUTIC USE |
CA2364178C (en) * | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
CA2474645C (en) * | 2002-02-01 | 2011-08-09 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
-
2003
- 2003-02-07 DE DE10304994A patent/DE10304994A1/en not_active Withdrawn
-
2004
- 2004-01-13 PE PE2004000064A patent/PE20040939A1/en not_active Application Discontinuation
- 2004-01-23 JP JP2006501585A patent/JP2006516980A/en active Pending
- 2004-01-23 KR KR1020057014116A patent/KR20050105447A/en not_active Application Discontinuation
- 2004-01-23 MX MXPA05007310A patent/MXPA05007310A/en active IP Right Grant
- 2004-01-23 WO PCT/EP2004/000550 patent/WO2004069266A2/en active IP Right Grant
- 2004-01-23 ME MEP-410/08A patent/MEP41008A/en unknown
- 2004-01-23 CA CA2514152A patent/CA2514152C/en not_active Expired - Fee Related
- 2004-01-23 DK DK04704552T patent/DK1594520T3/en active
- 2004-01-23 RU RU2005127862/15A patent/RU2329057C2/en not_active IP Right Cessation
- 2004-01-23 ES ES04704552T patent/ES2268622T3/en not_active Expired - Lifetime
- 2004-01-23 EP EP04704552A patent/EP1594520B1/en not_active Expired - Lifetime
- 2004-01-23 AT AT04704552T patent/ATE335500T1/en active
- 2004-01-23 CN CNB2004800034498A patent/CN1317029C/en not_active Expired - Fee Related
- 2004-01-23 AU AU2004210396A patent/AU2004210396A1/en not_active Abandoned
- 2004-01-23 BR BR0407333-9A patent/BRPI0407333A/en not_active IP Right Cessation
- 2004-01-23 RS YUP-2005/0565A patent/RS51029B/en unknown
- 2004-01-23 PT PT04704552T patent/PT1594520E/en unknown
- 2004-01-23 DE DE502004001159T patent/DE502004001159D1/en not_active Expired - Lifetime
- 2004-01-23 NZ NZ541680A patent/NZ541680A/en not_active IP Right Cessation
- 2004-01-23 PL PL376605A patent/PL206412B1/en unknown
- 2004-02-05 AR ARP040100363A patent/AR043036A1/en unknown
- 2004-02-05 TW TW093102562A patent/TW200505472A/en unknown
- 2004-02-06 MY MYPI20040362A patent/MY135827A/en unknown
-
2005
- 2005-06-27 ZA ZA200505177A patent/ZA200505177B/en unknown
- 2005-07-26 IL IL169899A patent/IL169899A0/en unknown
- 2005-08-03 CO CO05076615A patent/CO5690613A2/en not_active Application Discontinuation
- 2005-08-04 HR HRP20050701AA patent/HRP20050701B1/en not_active IP Right Cessation
- 2005-08-05 MA MA28425A patent/MA27618A1/en unknown
- 2005-09-06 NO NO20054144A patent/NO333903B1/en not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106009A patent/HK1085926A1/en not_active IP Right Cessation
- 2006-10-16 CY CY20061101482T patent/CY1105708T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL183160A0 (en) | Indazole-carboxamide compounds | |
TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
AU2002344951A1 (en) | Substituted piperazine and diazepanes as histamine h3 receptor agonists | |
HK1138276A1 (en) | Azetidine analogues of nucleosidase and phosphorylase inhibitors | |
WO2005062881A3 (en) | Gene therapy using transposon-based vectors | |
MX2007008614A (en) | Peptides with neuropeptide-2 receptor (y2r) agonist activity. | |
GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
MX2007005205A (en) | Sulfonyl-substituted bicyclic compounds as modulators of ppar. | |
MY137053A (en) | Pyrimidine derivatives and their use as cb2 modulators | |
EA200601160A1 (en) | 2,6-BISGETEROARIL-4-AMINOPYRIMIDINES AS ANTAGONISTS OF ADENOSIN RECEPTORS | |
DE602005016446D1 (en) | 5-HT4 receptor agonist compounds | |
ATE431824T1 (en) | QUINOLINONE-CARBOXAMIDE COMPOUNDS | |
NO20071594L (en) | Pyrimidine sulfonamide derivatives as chemokine receptor modulators | |
CO5660287A2 (en) | DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE | |
GT200300294A (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE | |
AU2003274307A1 (en) | 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist | |
NO20054144L (en) | Use of bradykinin-B2 receptor antagonists for the treatment of osteoarthrosis | |
AU2003215680A1 (en) | New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives | |
PE20050665A1 (en) | SELECTIVE ESTROGENS OF 8ß-VINYL-ESTRA-1,3,5 (10) -TRIEN-3,17ß-DIOL AND 17ß-FLUOR-9-VINYL-ESTRA-1,3,6 (10) -TRIEN-3,16ALPHA -DIOL | |
ATE329916T1 (en) | AZAINDOLYLPIPERIDINE DERIVATIVES AS ANTHISTAMINICS AND ANTIALLERGICS | |
UA92463C2 (en) | Pyrimidine sulphonamide derivatives as chemokine receptor modulators | |
ATE325115T1 (en) | PYRIMIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS | |
WO2004087905A3 (en) | Protein tyrosine phosphatase and inhibitors thereof | |
NO20023841L (en) | Use of glucocorticoid receptor antagonists for the prevention and treatment of diseases of the reproductive system in men | |
EA200601030A1 (en) | 7α, 17α-SUBSTITUTED 11β-HALOGENOSTEROIDS, METHODS FOR THEIR RECEPTION, APPLICATION AND PHARMACEUTICAL PREPARATION ON THEIR BASIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |